These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 25839904)

  • 1. Risk of Neoplasia in Pediatric Patients Receiving Growth Hormone Therapy--A Report From the Pediatric Endocrine Society Drug and Therapeutics Committee.
    Raman S; Grimberg A; Waguespack SG; Miller BS; Sklar CA; Meacham LR; Patterson BC
    J Clin Endocrinol Metab; 2015 Jun; 100(6):2192-203. PubMed ID: 25839904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth Hormone Deficiency and Treatment in Childhood Cancer Survivors.
    Pollock NI; Cohen LE
    Front Endocrinol (Lausanne); 2021; 12():745932. PubMed ID: 34745010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum insulin-like growth factor I (IGF-I), IGF-binding proteins 2 and 3, and the risk for development of malignancies in adults with growth hormone (GH) deficiency treated with GH: data from KIMS (Pfizer International Metabolic Database).
    Popovic V; Mattsson AF; Gaillard RC; Wilton P; Koltowska-Häggström M; Ranke MB
    J Clin Endocrinol Metab; 2010 Sep; 95(9):4449-54. PubMed ID: 20610598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term surveillance of growth hormone therapy.
    Rosenfeld RG; Cohen P; Robison LL; Bercu BB; Clayton P; Hoffman AR; Radovick S; Saenger P; Savage MO; Wit JM
    J Clin Endocrinol Metab; 2012 Jan; 97(1):68-72. PubMed ID: 22174422
    [No Abstract]   [Full Text] [Related]  

  • 5. Outcomes of growth hormone replacement therapy in survivors of childhood acute lymphoblastic leukemia.
    Leung W; Rose SR; Zhou Y; Hancock ML; Burstein S; Schriock EA; Lustig R; Danish RK; Evans WE; Hudson MM; Pui CH
    J Clin Oncol; 2002 Jul; 20(13):2959-64. PubMed ID: 12089225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone treatment and cancer risk.
    Banerjee I; Clayton PE
    Endocrinol Metab Clin North Am; 2007 Mar; 36(1):247-63. PubMed ID: 17336744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer risk following growth hormone use in childhood: implications for current practice.
    Ogilvy-Stuart AL; Gleeson H
    Drug Saf; 2004; 27(6):369-82. PubMed ID: 15144231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the GH-IGF axis play a role in cancer pathogenesis?
    Cohen P; Clemmons DR; Rosenfeld RG
    Growth Horm IGF Res; 2000 Dec; 10(6):297-305. PubMed ID: 11161960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does growth hormone cause cancer?
    Jenkins PJ; Mukherjee A; Shalet SM
    Clin Endocrinol (Oxf); 2006 Feb; 64(2):115-21. PubMed ID: 16430706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety Outcomes During Pediatric GH Therapy: Final Results From the Prospective GeNeSIS Observational Program.
    Child CJ; Zimmermann AG; Chrousos GP; Cummings E; Deal CL; Hasegawa T; Jia N; Lawrence S; Linglart A; Loche S; Maghnie M; Pérez Sánchez J; Polak M; Predieri B; Richter-Unruh A; Rosenfeld RG; Yeste D; Yorifuji T; Blum WF
    J Clin Endocrinol Metab; 2019 Feb; 104(2):379-389. PubMed ID: 30219920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of recombinant human insulin-like growth factor-I in treating children with short stature.
    Collett-Solberg PF; Misra M;
    J Clin Endocrinol Metab; 2008 Jan; 93(1):10-8. PubMed ID: 18165284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Considering GH replacement for GH-deficient adults with a previous history of cancer: a conundrum for the clinician.
    Yuen KC; Heaney AP; Popovic V
    Endocrine; 2016 May; 52(2):194-205. PubMed ID: 26732039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acromegaly, growth hormone and cancer risk.
    Renehan AG; Brennan BM
    Best Pract Res Clin Endocrinol Metab; 2008 Aug; 22(4):639-57. PubMed ID: 18971124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement.
    Boguszewski MCS; Boguszewski CL; Chemaitilly W; Cohen LE; Gebauer J; Higham C; Hoffman AR; Polak M; Yuen KCJ; Alos N; Antal Z; Bidlingmaier M; Biller BMK; Brabant G; Choong CSY; Cianfarani S; Clayton PE; Coutant R; Cardoso-Demartini AA; Fernandez A; Grimberg A; Guðmundsson K; Guevara-Aguirre J; Ho KKY; Horikawa R; Isidori AM; Jørgensen JOL; Kamenicky P; Karavitaki N; Kopchick JJ; Lodish M; Luo X; McCormack AI; Meacham L; Melmed S; Mostoufi Moab S; Müller HL; Neggers SJCMM; Aguiar Oliveira MH; Ozono K; Pennisi PA; Popovic V; Radovick S; Savendahl L; Touraine P; van Santen HM; Johannsson G
    Eur J Endocrinol; 2022 Apr; 186(6):P35-P52. PubMed ID: 35319491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of second neoplasm in childhood cancer survivors treated with GH: an analysis of GeNeSIS and HypoCCS.
    Woodmansee WW; Zimmermann AG; Child CJ; Rong Q; Erfurth EM; Beck-Peccoz P; Blum WF; Robison LL;
    Eur J Endocrinol; 2013 Apr; 168(4):565-73. PubMed ID: 23359434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone regimens in Australia: analysis of the first 3 years of treatment for idiopathic growth hormone deficiency and idiopathic short stature.
    Hughes IP; Harris M; Choong CS; Ambler G; Cutfield W; Hofman P; Cowell CT; Werther G; Cotterill A; Davies PS;
    Clin Endocrinol (Oxf); 2012 Jul; 77(1):62-71. PubMed ID: 21950731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GH-deficient survivors of childhood cancer: GH replacement during adult life.
    Murray RD; Darzy KH; Gleeson HK; Shalet SM
    J Clin Endocrinol Metab; 2002 Jan; 87(1):129-35. PubMed ID: 11788635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GH therapy and cancer risk in hypopituitarism: what we know from human studies.
    Pekic S; Popovic V
    Eur J Endocrinol; 2013 Nov; 169(5):R89-97. PubMed ID: 23935131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of in vivo growth hormone treatment on blood gene expression in adults with growth hormone deficiency reveals potential biomarkers to monitor growth hormone therapy.
    Fernández-Pérez L; Nóvoa J; Ståhlberg N; Santana-Farré R; Boronat M; Marrero D; Henríquez-Hernández L; Norstedt G; Flores-Morales A
    Clin Endocrinol (Oxf); 2010 Jun; 72(6):800-6. PubMed ID: 19849699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone replacement therapy in children: The use of growth hormone and IGF-I.
    Pfäffle R
    Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):339-52. PubMed ID: 26051295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.